Ingredion (INGR) Tops Q1 EPS by 56c; raises guidance

Ingredion (NYSE: INGR) reported Q1 EPS of $2.97, $0.56 better than the analyst estimate of $2.41. Revenue for the quarter came in at $1.81 billion versus the consensus estimate of $1.85 billion.

GUIDANCE:

Ingredion sees FY2025 EPS of $10.90-$11.60, versus the consensus of $11.04.

For earnings history and earnings-related data on Ingredion (INGR) click here.

You May Also Be Interested In

• Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral
• JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight
• Axis Capital Limited Downgrades National Aluminium (NACL:IN) to Sell (4)